The company plans to direct resources away from a drug developed by subsidiary Recognify Life Sciences and toward Atai’s ...

VINE senior center has received a $10,000 grant from the Mankato Clinic Foundation to support four new programs designed to ...

Recognify's CIAS trial for inidascamine missed its main endpoint but showed positive signals in cognitive domains and had a ...

The trial failed to achieve statistical significance in its goal of improved MCCB neurocognitive composite scores.

Initial results demonstrate numerical improvement of cognitive and functional measures with inidascamine across both active ...

The Penn Highlands Healthcare Parkinson’s Support Group will hold its next meeting on Wednesday, Aug. 13 from 2 to 3:30 p.m. at the Parkside Community Center, located at ...

Initial results demonstrate numerical improvement of cognitive and functional measures with inidascamine across both active treatment arms compared to placebo, but did not meet statistical ...

Inidascamine was well-tolerated, with a favorable safety profile consistent with previous studies. Importantly, no evidence of sedation, weight gain, or extrapyramidal symptoms was observed, which are ...